Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: A follow-up study in antipsychotic-naive patients with first-episode psychosis

Texto completo
Autor(es):
Mostrar menos -
Ota, Vanessa Kiyomi [1, 2] ; Noto, Cristiano [3, 2, 4] ; Gadelha, Ary [2, 3] ; Santoro, Marcos Leite [1, 2] ; Ortiz, Bruno Bertolucci [3] ; Andrade, Elvis Henrique [3] ; Tasso, Brazilio Carvalho [4] ; Nery Spindola, Leticia Maria [1, 2] ; Silva, Patricia Natalia [3, 1, 2] ; Abilio, Vanessa Costhek [3, 2, 5] ; Cardoso Smith, Marilia de Arruda [1] ; Sato, Joao Ricardo [2, 6] ; Brietzke, Elisa [2, 3] ; Cordeiro, Quirino [3, 4] ; Bressan, Rodrigo Affonseca [3, 2] ; Belangero, Sintia Iole [3, 1, 2]
Número total de Autores: 16
Afiliação do(s) autor(es):
[1] Univ Fed Sao Paulo UNIFESP, Dept Morphol & Genet, Div Genet, BR-04023900 Sao Paulo - Brazil
[2] Univ Fed Sao Paulo UNIFESP, LiNC Interdisciplinary Lab Clin Neurosci, BR-05039032 Sao Paulo - Brazil
[3] Univ Fed Sao Paulo UNIFESP, Dept Psychiat, Sao Paulo - Brazil
[4] ISCMSP, Dept Psychiat, Sao Paulo - Brazil
[5] Univ Fed Sao Paulo UNIFESP, Dept Pharmacol, Sao Paulo - Brazil
[6] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre - Brazil
Número total de Afiliações: 6
Tipo de documento: Artigo Científico
Fonte: JOURNAL OF PSYCHIATRIC RESEARCH; v. 56, p. 130-136, SEP 2014.
Citações Web of Science: 12
Resumo

A study of the gene expression levels in the blood of individuals with schizophrenia in the beginning of the disease, such as first-episode psychosis (FEP), is useful to detect gene expression changes in this disorder in response to treatment. Although a large number of genetic studies on schizophrenia have been conducted, little is known about the effects of antipsychotic treatment on gene expression. The aim of the present study was to examine differences in the gene expression in the blood of antipsychotic-naive FEP patients before and after risperidone treatment (N = 44) and also to verify the correlation with treatment response. In addition, we determined the correlations between differentially expressed genes and clinical variables. The expression of 40 neurotransmitter and neurodevelopment-associated genes was assessed using the RT2 Profiler (TM) PCR Array. The results indicated that the GABRR2 gene was downregulated after risperidone treatment, but no genes were associated with response to treatment and clinical variables after Bonferroni correction. GABRR2 downregulation after treatment can both suggest an effect of risperidone treatment or processes related to disease progression, either not necessarily associated with the improvement of symptoms. Despite this change was observed in blood, this decrease in GABRR2 mRNA levels might be an effect of changes in GABA concentrations or other systems interplay consequently to D2 blockage induced by risperidone, for example. Thus, it is important to consider that antipsychotics or the progression of psychotic disorders might interfere with gene expression. (C) 2014 Elsevier Ltd. All rights reserved. (AU)

Processo FAPESP: 10/19176-3 - Análise de expressão gênica e metilação de dna de pacientes em primeiro episódio psicótico virgens de tratamento
Beneficiário:Vanessa Kiyomi Ota Kuniyoshi
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 13/10498-6 - Aprendizado de máquina em neuroimagem: desenvolvimento de métodos e aplicações clínicas em transtornos psiquiátricos
Beneficiário:João Ricardo Sato
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 11/50740-5 - Prevenção na esquizofrenia e no transtorno bipolar da neurociência à comunidade: uma plataforma multifásica, multimodal e translacional para investigação e intervenção
Beneficiário:Rodrigo Affonseca Bressan
Linha de fomento: Auxílio à Pesquisa - Temático
Processo FAPESP: 10/08968-6 - Investigação de marcadores genéticos e epigenéticos: uma abordagem translacional para o tratamento de esquizofrenia
Beneficiário:Síntia Iole Nogueira Belangero
Linha de fomento: Auxílio à Pesquisa - Regular